Share Name Share Symbol Market Type Share ISIN Share Description
Sareum Holdings Plc LSE:SAR London Ordinary Share GB00B02RFS12 ORD 0.025P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.175 8.43% 2.25 2.20 2.30 2.25 2.10 2.10 19,010,708 11:03:58
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 -1.1 -0.0 - 73

Sareum Share Discussion Threads

Showing 12126 to 12148 of 12550 messages
Chat Pages: Latest  490  489  488  487  486  485  484  483  482  481  480  479  Older
DateSubjectAuthorDiscuss
18/12/2020
14:44
2p theres no other options here
spacedust
18/12/2020
12:37
I remember stating 2p + by Christmas. That was a couple of years back. Looking like it was the right prediction but the wrong Christmas. LOL. GLA. Hoping all holders have a happy and safe Christmas and a banging New Year! P.S. If anyone fancies getting me a pressie, a Lucy Verasamy would be much appreciated. Don’t bother clothing her.
norma_stitts
18/12/2020
11:52
thats big stuff
red5
18/12/2020
11:51
looks like i will be buying more issues science and nature and new scientist in then future.
red5
18/12/2020
11:44
1801. Autoimmune $55bn market. No effective new treatments in lupus for 40 years. Plus covid 19. The cytokine stirm that kills appears to be an aitoimmune . 1802. Caners that are interferon mediated Flt3. Leaukaemia Chk1. Anogenital cancer (colon. Cervical) plus as a combo lung cancer
mrsapeslaptop
18/12/2020
11:35
sorry but i am catching up to speed with this one as i have had this on my monitor but did not know why. what do SDC-1801 SDC-1802 SRA737 FLt3 do ?
red5
18/12/2020
11:11
Nice but dim.
bobby.ifa
18/12/2020
11:11
Red5 We have 4 main compounds, all which are either in the early or late stages of development. SDC-1801 SDC-1802 SRA737 FLt3 Each one of theses if they the come to market, and the main question is “if”, are worth hundreds of £M, if not £Billions. Many people have speculated what the market value and then subsequent share price of Sareum will be if these compounds are commercialised. We have a range from 6p to “pick a number”, and some have suggested £1+. Some are speculating that Sareum will get bought out by a big Pharma and are suggesting a share price of 25p +. But with all AIM small pharmas, the question is always “if”. If none of the compounds are successful, Sareum, and we who have large holdings, and have been here for a long time, are a busted flush. But with all the LTHs, we believe that the science is good, and that we are going to be rewarded for our patience. It may not be next week or next month, but I believe I’ll be cashing in my chips within 6 to 12 months. GLA and DYOR
curriedquaker
18/12/2020
10:43
really 25p to 250 thats really good i have to say that i bought these purely on speculation did not do any research what are the reason for going so high, it would be good to know i know they are doing something on covid.
red5
17/12/2020
13:32
25p to 250p 1.5p
spacedust
17/12/2020
13:09
so whats upsie and down sides for this one
red5
17/12/2020
13:00
Must n will finish 2p plus this week. Theres no other options
spacedust
17/12/2020
09:31
And then makes deals with them on all fronts. So world accepts their lies
spacedust
17/12/2020
08:57
Does it matter? As the world rolls over and accepts.
spacedust
17/12/2020
08:37
Lies do you think?????
silvergreyhead1
17/12/2020
08:36
Hello Norma that was one of my worries until I realised the deal was brokered by a reputed third party. They couldn't allow any shenanigans or their whole business would be finished. Well that was my hope anyway.
silvergreyhead1
17/12/2020
08:29
2p plus this week just look at the charts
spacedust
17/12/2020
08:29
World wide cases shoot up and sadly deaths too. China without any vaccine and no lockdowns have managed to keep c19 from spreading. How is this possible????
spacedust
17/12/2020
08:23
World wide cases shoot ip and sasly deaths too. China without any vaccine and no lockdowns have managed to keep c19 from spreading. How is this psossible????
spacedust
16/12/2020
23:37
The only part of this that I’m currently less than optimistic about is FLT3. I can’t help but think that a nation that treats Uighurs like they do will not bat an eyelid over screwing us out of milestones/royalties. I hope they learnt from the SRRA fiasco and have put a caveat in to name and shame them if they start playing silly beggars? I’d certainly not want 1801/1802 going to China unless it’s for utterly obscene upfront figures?
norma_stitts
15/12/2020
15:02
Think he was talking to Justrying
silvergreyhead1
15/12/2020
13:49
Yip. And we will finish blue today. I expect 2p no matter what and we will hit 2p one way or another
spacedust
15/12/2020
13:39
others having problems, so more market share for us IMO Incyte and Novartis announced a Phase III study of Jakafi (ruxolitinib), a first-in-class JAK1/JAK2 inhibitor, failed to hit endpoints as a treatment for patients 12 and up with COVID-19 associated cytokine storm. Https://www.pharmalive.com/jakafi-fails-to-reduce-covid-19-associated-cytokine-storm-complications/
andrbea
Chat Pages: Latest  490  489  488  487  486  485  484  483  482  481  480  479  Older
ADVFN Advertorial
Your Recent History
LSE
SAR
Sareum
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210423 10:26:38